These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7842223)

  • 1. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good?
    Barrett TE; Strom BL
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):574-7. PubMed ID: 7842223
    [No Abstract]   [Full Text] [Related]  

  • 2. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 3. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
    Furukawa CT; Kemp JP; Simons FE; Tinkelman DG
    Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623
    [No Abstract]   [Full Text] [Related]  

  • 4. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic studies of beta agonists and asthma deaths.
    Pearce N; Hensley MJ
    Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapeutic potentials of Berotec-100 in bronchial asthma patients].
    Emel'ianov AV; Shevelev SE; Shubin SA; Sinitsina TM; Fedoseev GB
    Klin Med (Mosk); 1998; 76(7):38-9. PubMed ID: 9742777
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence based answers--is salmeterol safe in asthma?
    Spurling G; Doust J
    Aust Fam Physician; 2006 Aug; 35(8):625-6. PubMed ID: 16894440
    [No Abstract]   [Full Text] [Related]  

  • 8. Confounding by indication and channeling over time: the risks of beta 2-agonists.
    Blais L; Ernst P; Suissa S
    Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma deaths in New Zealand: whodunnit?
    Blauw GJ; Westendorp RG
    Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta 2 agonists in asthma: relief, prevention, morbidity.
    Lancet; 1990 Dec; 336(8728):1411-2. PubMed ID: 1978875
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing patterns in asthma morbidity and mortality.
    Sears MR
    J Investig Allergol Clin Immunol; 1995; 5(2):66-72. PubMed ID: 7655702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine use of beta-adrenergic agonists in asthma.
    Wanner A; Sears MR
    Am J Respir Crit Care Med; 1995 Aug; 152(2):823. PubMed ID: 7633750
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bronchospasmolytic effect of adrenergic beta receptor agonists in bronchial asthma].
    Makel'skiĭ VV
    Ter Arkh; 1976; 40(2):57-60. PubMed ID: 9700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased asthma fatality in chronic administration of beta agonists?].
    Geisler LS
    Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bronchial asthma. Its treatment in the emergency ward].
    Diez Jarilla JL; Cruz Hernández JJ; del Pino Montes J; Sánchez Gascónf ; Laso Guzmán FJ
    Med Clin (Barc); 1981 Oct; 77(6):262-3. PubMed ID: 6119406
    [No Abstract]   [Full Text] [Related]  

  • 16. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".
    Pearce N; Beasley R; Crane J; Burgess C
    Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics].
    Ogawa C; Sano Y
    Nihon Rinsho; 1996 Nov; 54(11):3081-6. PubMed ID: 8950959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of severe life threatening asthma.
    Barnes NC; Kuitert LM
    Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-agonists and death from asthma.
    Pearce N; Crane J; Burgess C; Beasley R; Jackson R
    N Engl J Med; 1992 Jul; 327(5):355-7. PubMed ID: 1352379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.